SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Diversa Corporation (DVSA)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (60)12/31/2001 9:40:45 AM
From: tuck  Read Replies (1) of 144
 
>>SAN DIEGO, Dec. 31 /PRNewswire/ -- Diversa Corporation (Nasdaq: DVSA - news) today announced that it was awarded a milestone payment of $1.3 million from Zymetrics, Inc. in conjunction with research and development performed for Zymetrics. The milestone payment was earned as a result of Diversa's discovery and optimization of novel enzymes with potential application in feed and food processing.

Zymetrics is a contract joint venture formed in December 1999 between Diversa and Syngenta (NYSE: SYT - news) to commercialize functionally-differentiated enzymes for animal nutrition and crop processing. Zymetrics is developing novel enzymes to improve the efficiency and environmental sustainability of animal agriculture and enhance the quality and value of feed, food, and industrial products derived from crops. Diversa receives research funding from Zymetrics and will participate in profit-sharing on any products commercialized by the venture.<<

snip

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext